High-dose iron treatment has shown benefits compared with iron sucrose in a previous study, where high-dose of iron treatment (FCM) made similar post-treatment Hb levels, but was much more rapid compared to iron sucrose administration in patients with iron deficiency anemia [18]. Here, GSTM1 is linked to Iron deficiency anemia.